XTL Biopharmaceuticals Ltd. (A - XTLB - Financial Statement Analysis
All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.
In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.
Financial statement analysis updated: December 1, 2013
XTL Biopharmaceuticals Ltd. (A - SIC # 8731
|Ticker||Exchange||SIC #||Website||Latest Ticker|
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for XTL Biopharmaceuticals Ltd. (A
XTL BIOPHARMACEUTICALS LTD Financials - Jul 18th, 2013 11:04 am
XTL Biopharmaceuticals' ADRs Commence Trading on NASDAQ Stock Market - Jul 15th, 2013 11:30 am
XTL Biopharmaceuticals Returns to NASDAQ - Jul 10th, 2013 11:45 am
View All Current Headlines >>